Oyindamola Ikepo Ogunlaja
Clinical Assistant Professor, Neurology & Neurological Sciences
Bio
Dr. Ogunlaja is a board-certified, fellowship-trained neurologist. She provides patient care in the Stanford Headache Clinic. She is an assistant professor in the Department of Neurology, Headache Division.
Her specialized skills include Botox therapy for chronic migraine, trigger point injection procedures, and occipital nerve blocks.
Her prior experience includes serving as a consultant neurologist at King’s College Hospital in London.
Dr. Ogunlaja was a clinical research fellow in the Headache Group at King’s College. She was a physician member of the Dementia Consensus Panel of the Health and Aging in Africa Study.
She also conducted research at the Unit of Health-Care Epidemiology in the University of Oxford’s Department of Public Health. She investigated the epidemiology of patients hospitalized for sickle cell disease in England.
Dr. Ogunlaja has published in peer-reviewed journals including Headache and Current Pain and Headache Reports. She has presented her research findings to her peers at the International Headache Conference.
She is a member of the American Headache Society.
Clinical Focus
- Pain Medicine
Professional Education
-
Fellowship: Stanford University Dept of Neurology (2019) CA
-
Board Certification: American Board of Psychiatry and Neurology, Neurology (2018)
-
Residency: Brigham and Women's and Mass General Hospital Neurology Residency (2018) MA
-
Internship: Massachusetts General Hospital Internal Medicine Residency (2015) MA
-
Medical Education: King's College London School of Medicine (2009) United Kingdom
All Publications
-
New Daily Persistent Headache Syndrome Secondary to Clival Metastasis Within an Osseous Hemangioma.
Headache
2019
View details for DOI 10.1111/head.13655
View details for PubMedID 31535364
-
Subarachnoid Hemorrhage and Headache.
Current pain and headache reports
2019; 23 (6): 44
Abstract
PURPOSE FOR REVIEW: Subarachnoid hemorrhage is a serious and life-threatening medical condition which commonly presents with an acute headache. Unfortunately, it remains frequently misdiagnosed at initial presentation with dire consequences in terms of patient morbidity and mortality. The goal of this paper is to review salient features in the clinical history, as well as recently developed clinical decision rules, which can help determine which patients warrant further investigation for subarachnoid hemorrhage when the initial presentation is that of an acute headache.RECENT FINDINGS: A recent prospective observational study showed that occipital location, stabbing quality, presence of meningism, and onset of headache during exertion were characteristics in the clinical history that can distinguish the headache of SAH from other causes. The Ottawa headache rule is a clinical decision tool which was developed to help identify patients presenting to the ED with acute non-traumatic headache who require investigation to rule out subarachnoid hemorrhage. Using this tool, it is recommended that patients who meet any one of the following 6 criteria are investigated further: Onset greater than or equal to 40years, presence of neck pain or stiffness, witnessed loss of consciousness, onset during exertion, thunder clap headache (pain peaking within 1s), or limited neck flexion on exam. An informed and thoughtful approach that takes into account the timing, presentation, risk factors, and resources, as discussed here, should help distinguish between the patient that warrants further evaluation and intervention for SAH and one who does not. The Ottawa SAH rule is a useful clinical decision tool for young inexperienced clinicians in order to avoid missed diagnoses. However, its clinical value is limited by its low specificity. Clinical decision tools with higher specificity are needed.
View details for DOI 10.1007/s11916-019-0785-x
View details for PubMedID 31123920